Oversea-Chinese Banking Corp (OCBC)’s Regeneron Pharmaceuticals REGN Stock Holding History

Oversea-Chinese Banking Corp (OCBC)’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-604	Closed	-$466K	–	371
2025 Q4	$466K	Sell	604 -260	-30%	-$177K	0.01%	260
2025 Q3	$486K	Buy	864 +464	+116%	+$262K	0.01%	262
2025 Q2	$210K	Buy	+400	New	+$223K	0.01%	316
2024 Q4	–	Sell	-1,319	Closed	-$1.39M	–	436
2024 Q3	$1.39M	Buy	1,319 +978	+287%	+$1.09M	0.04%	204
2024 Q2	$358K	Buy	+341	New	+$331K	0.01%	308
2023 Q1	–	Sell	-593	Closed	-$428K	–	378
2022 Q4	$428K	Buy	+593	New	+$438K	0.02%	240

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Oversea-Chinese Banking Corp (OCBC)'s REGN Position: Q1 2026 in Review

Oversea-Chinese Banking Corp (OCBC) sold out of Regeneron Pharmaceuticals (REGN) in Q1 2026, closing a stake of 604 shares — an estimated $466K sold.

Oversea-Chinese Banking Corp (OCBC) first reported a position in REGN in Q4 2022 and held it in 6 quarters. The position peaked at $1.39M in Q3 2024. 1,396 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

Oversea-Chinese Banking Corp (OCBC) reported no remaining Regeneron Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Oversea-Chinese Banking Corp (OCBC) sold 604 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $466K.
Oversea-Chinese Banking Corp (OCBC) first reported a position in Regeneron Pharmaceuticals in Q4 2022 and held it in 6 quarters.
Oversea-Chinese Banking Corp (OCBC)'s Regeneron Pharmaceuticals position peaked at $1.39M in Q3 2024.
1,396 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q1 2026, filed 28 Apr 2026.